# TEMOZOLOMIDE
> **ANDA213328** · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2021-11-23
## Drug
- **FDA Application Number:** ANDA213328
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TEMOZOLOMIDE
- **Generic name:** TEMOZOLOMIDE
- **Active ingredients:** TEMOZOLOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NIVAGEN PHARMS INC
- **Manufacturer:** Nivagen Pharmaceuticals, Inc.
- **First approval:** 2021-11-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213328)
---
*AI Analytics · CC0 1.0*